Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma

BACKGROUND: Aidi Injection (ADI), a Chinese herbal preparation with anti-cancer activity, is used for the treatment of hepatocellular carcinoma (HCC). Several clinical studies have shown that co-administration of ADI with doxorubicin (DOX) is associated with reduced toxicity of chemotherapy, enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yuan, Pan, Jie, Zhu, Xiaoqing, Zhang, Shuai, Liu, Chunhua, Sun, Jia, Li, Yueting, Chen, Siying, Huang, Jing, Cao, Chuang, Wang, Yonglin, Li, Yongjun, Liu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419969/
https://www.ncbi.nlm.nih.gov/pubmed/34488896
http://dx.doi.org/10.1186/s40360-021-00515-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419969/
https://www.ncbi.nlm.nih.gov/pubmed/34488896
http://dx.doi.org/10.1186/s40360-021-00515-9

Ejemplares similares